Intratumoral vitamin D signaling and lethal prostate cancer
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgae055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Jane B Vaselkiv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Vitamin D, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, DF/HCC Specialized Programs in Research Excellence (SPORE) in Prostate Cancer.
Abstract (Originalsprache)
High circulating vitamin D levels and supplementation may lower prostate cancer mortality. To probe for direct effects of vitamin D signaling in the primary tumor, we assessed how activation of intratumoral vitamin D signaling in prostate cancer is associated with lethal prostate cancer during long-term follow-up. Among 404 participants with primary prostate cancer in the Health Professionals Follow-up Study and the Physicians’ Health Study, we defined a gene score of expected activated intratumoral vitamin D signaling consisting of transcriptionally upregulated (CYP27A1, CYP2R1, RXRA, RXRB, and VDR) and downregulated genes (CYP24A1 and DHCR7). We contrasted vitamin D signaling in tumors that progressed to lethal disease (metastases/prostate cancer-specific death, n = 119) over up to three decades of follow-up with indolent tumors that remained nonmetastatic for >8 years post-diagnosis (n = 285). The gene score was downregulated in tumor tissue compared with tumor-adjacent histologically normal tissue of the same men. Higher vitamin D gene scores were inversely associated with lethal prostate cancer (odds ratio for highest versus lowest quartile: 0.46, 95% confidence interval: 0.21–0.99) in a dose–response fashion and after adjusting for clinical and pathologic factors. This association appeared strongest among men with high predicted plasma 25-hydroxyvitamin D3 and men with body mass index ≥25 kg/m2. Findings were replicated with broader gene sets. These data support the hypothesis that active intratumoral vitamin D signaling is associated with better prostate cancer outcomes and provide further rationale for testing how vitamin D-related interventions after diagnosis could improve prostate cancer survival through effects on the tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Merck & Co., Inc., Kenilworth, NJ, United States.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
- Department of Pathology, Trinity College Dublin, Dublin, Ireland.
- Discovery Science, American Cancer Society, Atlanta, GA, United States.
- Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
ORCID-Profile: Jane B Vaselkiv, Cheng Peng, Konrad H Stopsack
Förderung
- NCI NIH HHS
- National Cancer Institute
- DF/HCC Specialized Programs in Research Excellence (SPORE) in Prostate Cancer
Zitieren
APA
Vaselkiv, J. B., Shui, I. M., Grob, S. T., Ericsson, C. I., Giovannucci, I., Peng, C., Finn, S. P., Mucci, L. A., Penney, K. L., & Stopsack, K. H. (2024). Intratumoral vitamin D signaling and lethal prostate cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgae055
Vancouver
Vaselkiv JB, Shui IM, Grob ST, Ericsson CI, Giovannucci I, Peng C, et al. Intratumoral vitamin D signaling and lethal prostate cancer. Carcinogenesis. 2024. doi:10.1093/carcin/bgae055
BibTeX
@article{Vaselkiv2024,
author = {Vaselkiv, Jane B and Shui, Irene M and Grob, Sydney T and Ericsson, Caroline I and Giovannucci, Isabel and Peng, Cheng and Finn, Stephen P and Mucci, Lorelei A and Penney, Kathryn L and Stopsack, Konrad H},
title = {Intratumoral vitamin D signaling and lethal prostate cancer},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgae055}
}
EUVIMED